Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather Landau

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Hematology. American Society of Hematology. Education Program|December 10, 2021
AL amyloidosis: untangling new therapiesSusan Bal, Heather Landau
Journal of Hematology & Oncology|November 22, 2011
Light chain (AL) amyloidosis: update on diagnosis and managementMichael Rosenzweig, Heather Landau
Current Hematologic Malignancy Reports|April 29, 2010
Clinical manifestations and treatment of newly diagnosed acute lymphoblastic leukemia in adultsHeather Landau, Nicole Lamanna
Hematology/Oncology Clinics of North America|September 13, 2014
Treatment of transplant-eligible patients with multiple myeloma in 2014Heather Landau, Sergio Giralt
Current Oncology Reports|August 12, 2006
Clinical trials report. Minimal residual disease quantification in adult acute lymphoblastic leukemiaHeather Landau, Mark A Weiss
Leukemia & Lymphoma|August 30, 2017
Managing multiple myeloma in elderly patientsEvan Diamond, Oscar B Lahoud, Heather Landau
American Journal of Hematology|May 26, 2026
Common Threshold of Measurable Disease Improperly Excludes Patients With AL Amyloidosis From Clinical TrialsEugene Brailovski, Patrick Gould, Hani Hassoun, et al.
Frontiers in Oncology|July 15, 2024
Treatment of AL amyloidosis in the era of novel immune and cellular therapiesCaitlin Sarubbi, Hesham Abowali, Cindy Varga, et al.
British Journal of Haematology|November 16, 2019
Kidney transplantation in AL Amyloidosis: is it time to maximize access?Insara J Sathick, Cara A Rosenbaum, Victoria Gutgarts, et al.
Advances in Therapy|October 27, 2015
Light Chain Amyloidosis: Patient Experience Survey from the Amyloidosis Research ConsortiumIsabelle Lousada, Raymond L Comenzo, Heather Landau, et al.
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Hematology. American Society of Hematology. Education Program|December 10, 2021
AL amyloidosis: untangling new therapiesSusan Bal, Heather Landau
Journal of Hematology & Oncology|November 22, 2011
Light chain (AL) amyloidosis: update on diagnosis and managementMichael Rosenzweig, Heather Landau
Current Hematologic Malignancy Reports|April 29, 2010
Clinical manifestations and treatment of newly diagnosed acute lymphoblastic leukemia in adultsHeather Landau, Nicole Lamanna
Hematology/Oncology Clinics of North America|September 13, 2014
Treatment of transplant-eligible patients with multiple myeloma in 2014Heather Landau, Sergio Giralt
Current Oncology Reports|August 12, 2006
Clinical trials report. Minimal residual disease quantification in adult acute lymphoblastic leukemiaHeather Landau, Mark A Weiss
Leukemia & Lymphoma|August 30, 2017
Managing multiple myeloma in elderly patientsEvan Diamond, Oscar B Lahoud, Heather Landau
American Journal of Hematology|May 26, 2026
Common Threshold of Measurable Disease Improperly Excludes Patients With AL Amyloidosis From Clinical TrialsEugene Brailovski, Patrick Gould, Hani Hassoun, et al.
Frontiers in Oncology|July 15, 2024
Treatment of AL amyloidosis in the era of novel immune and cellular therapiesCaitlin Sarubbi, Hesham Abowali, Cindy Varga, et al.
British Journal of Haematology|November 16, 2019
Kidney transplantation in AL Amyloidosis: is it time to maximize access?Insara J Sathick, Cara A Rosenbaum, Victoria Gutgarts, et al.
Advances in Therapy|October 27, 2015
Light Chain Amyloidosis: Patient Experience Survey from the Amyloidosis Research ConsortiumIsabelle Lousada, Raymond L Comenzo, Heather Landau, et al.
Pageof 10